Published in MBio on July 28, 2015
Pyocyanin degradation by a tautomerizing demethylase inhibits Pseudomonas aeruginosa biofilms. Science (2016) 1.39
SutA is a bacterial transcription factor expressed during slow growth in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2016) 0.86
Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum. Proc Natl Acad Sci U S A (2015) 0.85
Facultative Control of Matrix Production Optimizes Competitive Fitness in Pseudomonas aeruginosa PA14 Biofilm Models. Appl Environ Microbiol (2015) 0.84
The physiology of growth arrest: uniting molecular and environmental microbiology. Nat Rev Microbiol (2016) 0.82
Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens. J Clin Microbiol (2015) 0.79
Gel-Entrapped Staphylococcus aureus Bacteria as Models of Biofilm Infection Exhibit Growth in Dense Aggregates, Oxygen Limitation, Antibiotic Tolerance, and Heterogeneous Gene Expression. Antimicrob Agents Chemother (2016) 0.76
Ecological networking of cystic fibrosis lung infections. NPJ Biofilms Microbiomes (2016) 0.76
Pseudomonas aeruginosa Aggregate Formation in an Alginate Bead Model System Exhibits In Vivo-Like Characteristics. Appl Environ Microbiol (2017) 0.76
Glutathione-Disrupted Biofilms of Clinical Pseudomonas aeruginosa Strains Exhibit an Enhanced Antibiotic Effect and a Novel Biofilm Transcriptome. Antimicrob Agents Chemother (2016) 0.75
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis. Front Pharmacol (2016) 0.75
Human calprotectin affects the redox speciation of iron. Metallomics (2017) 0.75
Optimised chronic infection models demonstrate that siderophore 'cheating' in Pseudomonas aeruginosa is context specific. ISME J (2017) 0.75
Hyperbaric oxygen sensitizes anoxic Pseudomonas aeruginosa biofilm to ciprofloxacin. Antimicrob Agents Chemother (2017) 0.75
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 40.22
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A (2006) 8.85
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest (2002) 5.94
Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol (2010) 5.63
Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol (2012) 5.35
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell (2002) 4.94
Diffusion in biofilms. J Bacteriol (2003) 4.22
Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl Environ Microbiol (1998) 3.72
Production of volatile sulfur compounds by microorganisms. Annu Rev Microbiol (1972) 3.70
Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J (2006) 3.37
Pathogenesis of cystic fibrosis. Lancet (1993) 3.34
Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J Bacteriol (1984) 3.25
Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol (2007) 3.22
Acetogenesis and the Wood-Ljungdahl pathway of CO(2) fixation. Biochim Biophys Acta (2008) 3.08
Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu Rev Med (2007) 2.85
H2S: a universal defense against antibiotics in bacteria. Science (2011) 2.69
Production and fate of methylated sulfur compounds from methionine and dimethylsulfoniopropionate in anoxic salt marsh sediments. Appl Environ Microbiol (1987) 2.60
The particulate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst. J Clin Invest (1976) 2.43
Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J (2010) 2.33
Hydrogen sulfide as a gasotransmitter. J Neurochem (2010) 2.30
Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol (2007) 2.25
Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol (2004) 1.96
State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? Respir Res (2003) 1.86
Amino acid and glucose fermentation by Treponema denticola. Arch Mikrobiol (1971) 1.81
Aerobic growth at nanomolar oxygen concentrations. Proc Natl Acad Sci U S A (2010) 1.79
Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung. MBio (2014) 1.74
Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol (2013) 1.63
Metatranscriptomics of the human oral microbiome during health and disease. MBio (2014) 1.60
Redox reactions of phenazine antibiotics with ferric (hydr)oxides and molecular oxygen. Environ Sci Technol (2008) 1.58
Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J Bacteriol (1996) 1.56
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? J Cyst Fibros (2011) 1.53
Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am J Respir Cell Mol Biol (2012) 1.52
Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax (2002) 1.51
The microbiology of deep-sea hydrothermal vent plumes: ecological and biogeographic linkages to seafloor and water column habitats. Front Microbiol (2013) 1.30
Effect of anaerobiosis and nitrate on gene expression in Pseudomonas aeruginosa. Infect Immun (2005) 1.26
Nitrate sensing and metabolism modulate motility, biofilm formation, and virulence in Pseudomonas aeruginosa. Infect Immun (2007) 1.24
Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome (2013) 1.23
Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities. J Cyst Fibros (2012) 1.23
Endogenous hydrogen sulfide in patients with COPD. Chest (2005) 1.22
Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. MBio (2013) 1.22
Diagnosis and treatment of cystic fibrosis. Respiration (2000) 1.19
Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax (2009) 1.17
Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J Bacteriol (2008) 1.13
Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model. J Bacteriol (2015) 1.13
Heterogeneity of the composition and thickness of tracheal mucus in rats. Am J Physiol (1997) 1.12
Breath sulfides and pulmonary function in cystic fibrosis. Proc Natl Acad Sci U S A (2005) 1.08
Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Environ Microbiol (2012) 1.06
Hydrogen sulfide and nitric oxide interactions in inflammation. Nitric Oxide (2014) 1.01
Phenazine redox cycling enhances anaerobic survival in Pseudomonas aeruginosa by facilitating generation of ATP and a proton-motive force. Mol Microbiol (2014) 0.99
A microtiter plate assay for Staphylococcus aureus biofilm quantification at various pH levels and hydrogen peroxide supplementation. New Microbiol (2010) 0.98
Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. PLoS One (2014) 0.96
Elevated incidence of dental caries in a mouse model of cystic fibrosis. PLoS One (2011) 0.95
Morphological optimization for access to dual oxidants in biofilms. Proc Natl Acad Sci U S A (2013) 0.92
The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome (2014) 0.91
Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J Cyst Fibros (2011) 0.90
Methods for ASL measurements and mucus transport rates in cell cultures. Methods Mol Biol (2011) 0.90
Mathematical modeling of molecular diffusion through mucus. Adv Drug Deliv Rev (2008) 0.89
Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"? Expert Opin Ther Targets (2012) 0.88
Oxygen diffusive barriers of rat distal colon: role of subepithelial tissue, mucosa, and mucus gel layer. Dig Dis Sci (2000) 0.88
Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations. Pediatr Pulmonol (2009) 0.86
Effects of water stratification and mixing on microbial community structure in a subtropical deep reservoir. Sci Rep (2014) 0.84
Pseudomonas aeruginosa triggers CFTR-mediated airway surface liquid secretion in swine trachea. Proc Natl Acad Sci U S A (2014) 0.81
Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent. J Med Microbiol (2014) 0.81
Correlation between serum H2S and pulmonary function in children with bronchial asthma. Mol Med Rep (2012) 0.80
Tracking microbial habitats in subseafloor sediments. Proc Natl Acad Sci U S A (2012) 0.79
Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum. Int J Med Microbiol (2014) 0.79
A study of sulfur-containing compounds in mouth- and nose-exhaled breath and in the oral cavity using selected ion flow tube mass spectrometry. J Breath Res (2008) 0.78
A sensor system for monitoring the simple gases hydrogen, carbon monoxide, hydrogen sulfide, ammonia and ethanol in exhaled breath. J Breath Res (2008) 0.78
Hydrogen sulfide as a potential biomarker of asthma. Expert Rev Respir Med (2013) 0.77
Methane production in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr (1988) 0.77
The timing of diammonium phosphate supplementation of wine must affects subsequent H2S release during fermentation. J Appl Microbiol (2009) 0.76